Advice
following an abbreviated submission:
dorzolamide 2% preservative-free unit-dose eye drops (Trusopt®) are accepted for restricted use in NHS Scotland for the treatment of elevated intra-ocular pressure in ocular hypertension, open-angle glaucoma and pseudo-exfoliative glaucoma. They are licensed as adjunctive therapy to beta-blockers and as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contra-indicated.
This preparation is substantially more expensive than the equivalent multi-dose eye drop preparation and should be restricted to use in patients for whom dorzolamide is appropriate and who have proven sensitivity to the preservative benzalkonium chloride.
Download detailed advice36KB (PDF)
Medicine details
- Medicine name:
- dorzolamide (Trusopt)
- SMC ID:
- 238/06
- Indication:
- Elevated intra-ocular pressure in ocular hypertension, open-angle glaucoma and pseudo-exfoliative glaucoma
- Pharmaceutical company
- MSD
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 05 May 2006